Viewing Study NCT04971161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:51 PM
Ignite Modification Date: 2026-02-02 @ 2:20 PM
Study NCT ID: NCT04971161
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2021-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Sponsor: RHEACELL GmbH & Co. KG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin Ulcer Venous Stasis Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Venous Ulcer View
None ABCB5 View
None Allogeneic View
None Dermal mesenchymal stromal cells View
None varicose ulcer View
None skin ulcer View
None advanced therapy medicinal product View
None somatic cell therapy View
None phase IIb View